Abametapir

185 interactions 129 explained in plain English 2 cited references
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Abametapir Zaleplon Explained Increased exposure of CYP3A4 substrate Details Abametapir Ziprasidone Geodon Explained Increased exposure of CYP3A4 substrate Details Abametapir Zolpidem Ambien Explained Increased exposure of CYP3A4 substrate Details Abametapir Aripiprazole Injection Abilify Increased exposure of CYP3A4 substrate Details Abametapir Abiraterone Abirtega Increased exposure of CYP3A4 substrate Details Abametapir Cabozantinib (Thyroid Cancer) Cabometyx Increased exposure of CYP3A4 substrate Details Abametapir Cyclophosphamide Injection Cytoxan® Injection Increased exposure of CYP2B6 substrates Details Abametapir Cyclosporine Injection Atopica Increased exposure of CYP3A4 substrate Details Abametapir Cyclosporine Ophthalmic Cequa Increased exposure of CYP3A4 substrate Details Abametapir Dexamethasone Injection Decadron Increased exposure of CYP3A4 substrate Details Abametapir Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) Increased exposure of CYP3A4 substrate Details Abametapir Diazepam Nasal Spray Valtoco Increased exposure of CYP3A4 substrate Details Abametapir Diazepam Rectal Diastat Increased exposure of CYP3A4 substrate Details Abametapir Dihydroergotamine Injection DHE-45® Injection Increased exposure of CYP3A4 substrate Details Abametapir Dihydroergotamine Nasal Spray Migranal Increased exposure of CYP3A4 substrate Details Abametapir Docetaxel Injection Beizray Increased exposure of CYP3A4 substrate Details Abametapir Eravacycline Injection Xerava Increased exposure of CYP3A4 substrate Details Abametapir Estradiol Topical Divigel Increased exposure of CYP3A4 substrate Details Abametapir Estradiol Transdermal Patch Alora® Increased exposure of CYP3A4 substrate Details Abametapir Fentanyl Transdermal Patch Duragesic® Increased exposure of CYP3A4 substrate Details Abametapir Hydrocortisone Injection A-Hydrocort® Increased exposure of CYP3A4 substrate Details Abametapir Ifosfamide Injection Ifex Increased exposure of CYP3A4 substrate Details Abametapir Irinotecan Injection Camptosar Increased exposure of CYP3A4 substrate Details Abametapir Irinotecan Lipid Complex Injection Onivyde® Increased exposure of CYP3A4 substrate Details Abametapir Lurbinectedin Injection Zepzelca Increased exposure of CYP3A4 substrate Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.